Convalescent Plasma for Treatment of COVID-19
NCT04649879
·
clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
59
Enrollment
OTHER
Sponsor class
Conditions
Covid19
Interventions
BIOLOGICAL:
SARS-CoV-2 convalescent plasma
OTHER:
Standard of care
Sponsor
Joakim Dillner
Collaborators
[object Object]
[object Object]
[object Object]